High‐Dose Recombinant Canarypox Vaccine Expressing HIV‐1 Protein, in Seronegative Human Subjects

• 1 October 2005
• journal article
• clinical trial
• Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
• Vol. 192  (7) , 1249-1259
• https://doi.org/10.1086/432915

Abstract

Keywords

• PROTEIN
• VACCINE
• VIRUS
• HIV
• ADULTS
• OPTIMIZE
• CTL
• RECIPIENTS
• TCID50
• CANARYPOX